JoVE Logo

Войдите в систему

1.14 : Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological damage.

Elderly patients are also usually given smaller doses of medication. This is because aging can significantly affect drug disposition. Moreover, if an elderly patient has multiple chronic diseases and takes numerous drugs, this could result in a range of adverse reactions.

Pregnant women present another unique case because drugs can cross the placenta, which could lead to teratogenic effects, causing fetal developmental abnormalities.

Patients with liver disease are usually advised to take smaller doses of drugs over extended periods. This recommendation stems from the fact that a damaged liver is less efficient at metabolizing and detoxifying drugs.

Intravenous administration of drugs allows these substances to enter the bloodstream directly, bypassing the gastrointestinal (GI)tract and hepatic metabolism, resulting in a quick response to the drug. In contrast, orally administered drugs need to pass through the GI tract and are subject to hepatic metabolism before they enter the systemic circulation, which generally results in a slower response

Теги

Drug ResponseInfantsYoung ChildrenMedication DosesOrgan FunctionDrug MetabolismBlood brain BarrierCentral Nervous SystemElderly PatientsChronic DiseasesAdverse ReactionsPregnant WomenPlacenta CrossingTeratogenic EffectsLiver DiseaseIntravenous AdministrationGastrointestinal TractHepatic Metabolism

Из главы 1:

article

Now Playing

1.14 : Factors Affecting Drug Response: Overview

General Pharmacological Principles

1.7K Просмотры

article

1.1 : Разработка лекарств: обзор

General Pharmacological Principles

7.2K Просмотры

article

1.2 : Доклиническая разработка: обзор

General Pharmacological Principles

4.1K Просмотры

article

1.3 : Клинические испытания: обзор

General Pharmacological Principles

2.6K Просмотры

article

1.4 : Номенклатура лекарственных средств

General Pharmacological Principles

1.5K Просмотры

article

1.5 : Регулирование лекарственных средств

General Pharmacological Principles

1.3K Просмотры

article

1.6 : Классы и категории лекарственных средств

General Pharmacological Principles

1.8K Просмотры

article

1.7 : Связи лекарственно-рецепторных соединений

General Pharmacological Principles

2.6K Просмотры

article

1.8 : Лекарственно-рецепторное взаимодействие

General Pharmacological Principles

4.7K Просмотры

article

1.9 : Пути введения препарата: обзор

General Pharmacological Principles

5.3K Просмотры

article

1.10 : Пути введения препарата: Энтеральный

General Pharmacological Principles

3.1K Просмотры

article

1.11 : Пути введения препарата: парентеральный

General Pharmacological Principles

1.8K Просмотры

article

1.12 : Дополнительные пути введения препарата

General Pharmacological Principles

2.7K Просмотры

article

1.13 : Рецептурные, безрецептурные и орфанные препараты

General Pharmacological Principles

668 Просмотры

JoVE Logo

Исследования

Образование

О JoVE

Авторские права © 2025 MyJoVE Corporation. Все права защищены